Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
CMS Needs Regulatory Science, Chief Scientist To Coordinate With US FDA, Former Official Says
Feb 01 2022
•
By
Derrick Gingery
A CMS Office of Chief Scientist and Office of Regulatory Science could help it coordinate actions with the FDA, Sean Tunis argued. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet